Pharmaceutical Aspects of Biotechnology Training

该计划的目标是培训制药科学家处理产品的开发。 产生于生物技术研究。由于发展生物技术的难度和复杂性-- 对于衍生药物，有必要培养一种新的能够应对 跨学科方法对生物、化学和制药发展的需求 通过整合数学、物理、生物学、分子生物学和化学来解决困难的科学 在设计未来的治疗剂方面的问题。这种新型的科学家也可以被安置在 学术机构扩大对药物生物技术科学家的教育培训 未来。这一培训计划已经实施了20年，每年有8名学生和34名教职员工 导师。本培训项目主要研究两个领域：(1)传统的《药剂学》 包括形成、分析和传递的领域；(2)蛋白质结构和生物信息学领域。 这34名教师导师来自四个不同的系，包括化学、药物化学、 分子生物科学和药物化学。教员导师还参与了几项 堪萨斯大学的其他项目，包括亚当斯生物分析化学研究所， 生物工程计划、生物信息学中心和蛋白质结构卓越中心 和功能。指导委员会监督培训方案的所有方面和Siahaan博士(PI) 担任委员会主席。学生将从被提名的申请者中挑选出来 由各参赛院系的教员导师主持。指导委员会将挑选学员 每年从提名学生中脱颖而出。学生的进展将在每季度的会议和 由受训人员在指导委员会一名成员的监督下组织的年度研讨会。 学员将由培训计划提供最长两年的支持，以及过去的学员 尚未毕业的学生应参加培训计划管理的所有活动。 在工业界和学术界工作满五年的校友将被邀请参加 在年度研讨会上介绍他们的研究成果。校友将就培训计划提供反馈 并将反馈意见用于提高未来培训项目的质量。 相关性(请参阅说明)： 该计划的目标是培训制药科学家处理产品的开发。 产生于生物技术研究。这一培训计划是为了满足培养出一种新的 未来的科学家可以对发现和开发治疗剂的复杂性做出反应 源自生物技术研究。希望这些未来的科学家将提高 成功地开发了这些未来的治疗剂，从工作台到床边。

The objective of this program is to train pharmaceutical scientists to handle the development of products arising from biotechnology research. Due to the difficulty and complex nature of developing biotechnology- derived drugs, it is necessary to train a new "breed" of pharmaceutical scientists who can respond to the needs of interdisciplinary approaches for the advancements of biological, chemical, and pharmaceutical sciences by integrating mathematics, physics, biology, molecular biology, and chemistry to solve difficult problems in designing therapeutic agents of the future. This new type of scientist could also be placed in academic institutions to expand the educational training of pharmaceutical biotechnology scientists of the future. This training program has been in existence for 20 years with 8 students per year and 34 faculty mentors. There are two major areas of research in this training program: (1) the traditional"Pharmaceutics" area that includes formation, analysis, and delivery and (2) the protein structure and bioinformatics area. The 34 faculty mentors are from four different departments, including Chemistry, Medicinal Chemistry, Molecular Biosciences, and Pharmaceutical Chemistry. The faculty mentors are also involved in several other programs within The University of Kansas, including the Adams Institute for Bioanalytical Chemistry, the Bioengineering Program, the Bioinformatics Center, and the Center of Excellence for Protein Structure and Function. The Steering Committee oversees all aspects of the training program and Dr. Siahaan (PI) serves as the committee chair. The students will be selected from a pool of applicants that are nominated by the faculty mentors from the participating departments. The Steering Committee will select the trainees from the nominated students each year. The students' progress will be monitored in quarterly meetings and annual symposia organized by the trainees under the supervision of a member of the Steering Committee. The trainees will be supported by the training program for a maximum of two years and the past trainees who are not yet graduated are expected to participate in all activities administered by the training program. The alumni of this program who have been working for five years in industry and academia will be invited to present their research at the yearly symposium. The alumni will provide feedback on the training program and the feedback will be used to improve the quality of the training program in the future. RELEVANCE (See instructions): The objective of this program is to train pharmaceutical scientists to handle the development of products arising from biotechnology research. This training program is fulfilling the need to produce a new "breed" of future scientists that can respond to the complex nature of discovering and developing therapeutic agents derived from biotechnology research. The hope is that these future scientists will improve the probability of success in developing these future therapeutic agents from the bench to the bedside.